IL1B and metabolic dysfunction-associated steatotic liver disease: Increased TNF-α promotes the activation of NLRC4 inflammasome in the liver, which improves the production of IL-18 and IL-1β, triggers hepatocyte pyroptosis, and accelerates NAFLD progress [93].